Ann: Positive Nine Month RA Results For Mesoblast Cell Therapy, page-24

It was an interesting broadcast today and two things struck me:

1. The Prof was saying that the MPC 300 IV should be used as the first line of treatment rather than doctors using the current drugs which do not offer much relief or is not a cure. The MPC 300IV is most effective if used at the onset and improves the quality of life for the patient.
2. As the market is in the $billions, if MPC 300IV is used it will cause many companies which are now producing alternate drugs for relief to lose their source of income.

Hence choosing a partner to go with becomes a critical issue. He mentioned that there are about 7 companies which MSB has the option of partnering with and I believe that they are looking for the best deal they can get and the impression I get is that it will be one company for the all the products rather than a few. The Prof is certainly in the drivers seat and I am certain we shall be having some good news very shortly.